People are everything.
Yoram Drucker
Co-Founder
Yoram Drucker - Co-Founder
Serial entrepreneur for more than 20 years. Co-founded several Biotech companies, such as Pluristem (NASDAQ: PSTI), Brainstorm (NASDAQ: BCLI)
and InnoCan (CSE: INNO)
Gabriel Eldor
Co-Founder and CEO
Gabriel Eldor - CEO and Co-Founder
Entrepreneur and an expert in Information and advanced technologies, Gabriel has established several successful high tech and biotech startup companies that are currently publicly listed.
Gabriel navigated multibillion dollar infrastructure deals in emerging markets, additionally, he has established an advanced 600 beds hospital.
Prof. Daniel Offen
Co-Founder and Head of ProtEx Exosome Project
Prof. Daniel Offen - Co-Founder and Head of ProtEx Project
Head of the Translational Neurosciences Lab at Sackler School of Medicine and Sagol School of Neuroscience, Tel-Aviv University. Expert in neurodegenerative diseases, specifically in stem cell and gene therapy. Published over 150 original scientific papers on neurodegenerative diseases and co-inventor in over a dozen patents as well as a Scientific founder of several Biotech companies.
Prof. Illana Gozes
VP Drug Development and Head of NAP Project
Prof. Illana Gozes - Scientific Advisor and Head of NAP Project
Professor Emerita, Chair for the Investigation of Growth Factors, Head of the Laboratory for Molecular Neuroendocrinology Department of Human Molecular Genetics and Biochemistry Faculty of Medicine and Super Center for Brain Studies, School of Neuroscience, Tel Aviv University Israel.
BSc, Tel Aviv University, PhD, Weizmann Institute, Israel, postdoc. MIT and Salk Institute, USA, Senior Scientist/Associate Professor, Weizmann Institute, Fogarty Scholar, NIH, USA, currently, Professor (Emerita) for Clinical Biochemistry at Tel Aviv University (mentoring numerous students). Published ~360 papers in neuroscience and inventor of numerous patents. She won many awards of excellence including Tel Aviv University’s Vice President Award, Olson Prize, Julodan Prize, Teva Prize, Neufeld Award, Hanse-Wissenschaftskolleg (HWK) fellowship, Humboldt Award, Landau Prize for Life Achievements, 2013. Ex-President of the Israel Society for Neuroscience (honorary member 2020), served on the Governing Committee and Board of Governors of Tel Aviv University and the Council for Higher Education of Israel.
Richard Serbin
Advisory Board
Richard Serbin - Advisory Board
Richard Serbin is a regulation attorney, a patent attorney, and a pharmacist. He has worked at Revlon and Revlon Healthcare as Chief FDA Counsel; and at Johnson & Johnson Corporation as FDA Counsel and subsequently as VP of Corporate Development.
Richard served on the Board of Directors of 16 of Johnson & Johnson’s US and foreign subsidiaries and established several US and International Medical Communication Companies which were acquired by large international companies. Richard is the co-founder of Bio-Imaging Technologies which used NASA’s LANDSAT technology for clinical evaluations.
Richard has extensive experience dealing with FDA issues and with licensing and acquisition activities and strategic planning.
Prof. Itzhak Haviv
Scientific Advisor
Prof. Itzhak Haviv - Scientific Advisor
Prof. Haviv has completed his Ph.D from Weizmann Institute of Science (Shaul lab, biochemistry of pX-HBV) and postdoctoral studies from University of California, Berkeley (c/o Tjian lab, head, HHMI). He is the director of cancer research center in the Faculty of medicine in the Galilee of Bar Ilan University. He has an affiliate position in the University of Melbourne for 11 years, and at Peter MacCallum Cancer Centre, Australia for 16 years. He co-founded the Australian Ovarian Cancer Study (166 manuscripts) and has published more than 60 papers in reputed journals.
Dotan Weiss
Board Member
Dotan Weiss - Board Member
New business development and digital go-to-market innovation expert with experience in the home care, personal care & health care sectors. Dotan is currently leading the innovation arm of P&G’s Oral Health Ventures and has previously led P&Gs digital CRM platform globally and the skin care business in Central Eastern Europe, Turkey and South Africa.
Dotan also bring vast experience in the BigData and analytics space where he managed the big data platforms for Comverse Technologies (Currently MVNR) and was a product manager for BigData systems in the Israeli elite intelligence corps.
Daniel Bartal
Board Member
Daniel Bartal - Board Member
Graduate Chemistry and Biology, TAU. 25 years of experience in various scientific, technological and engineering centered corporations, both as an entrepreneur and technologist. In this capacity Daniel worked for government owned entities, as well as in the private sector. Some of the companies founded include MegaGiga Networks (acquired 2000), Delixi (acquired 2007), Taxibot (developed for the IAI, 2012), Jasper Card (currently in closing of acquisition), Horizon-IC, GetPocketful, Dien-A Mollecular Biology Ltd, Advanced Concepts in Biology LLC, Biological Principles Lab Ltd, and others.